Shao, Iris Yuefan
Suglia, Shakira F.
An, Weihua
Mendez, David
Vaccarino, Viola
Alonso, Alvaro
Funding for this research was provided by:
National Institutes of Health (U54CA229974, K24HL148521.)
U.S. Food and Drug Administration (U54CA229974)
National Cancer Institute (U54CA229974)
Article History
Received: 5 December 2022
Accepted: 28 November 2023
First Online: 11 December 2023
Declarations
:
: The use of the data was reviewed and approved by the Institutional Review Board at Emory University and the Add Health study review boards. This study used secondary data from the Add Health study (ExternalRef removed). The Add Health study had obtained informed consent from all subjects and/or their legal guardian(s) and ensured confidentiality, anonymity, and privacy of all subjects and/or their legal guardian(s). We confirm that all methods were carried out following relevant guidelines, and regulations and conducted per the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.